Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

SION

+ Watchlist+ Portfolio

Sionna Therapeutics, Inc.

Regulated industrySells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$3.07
52-Week Range
$2.89 – $54.97
Market Cap
$134.35M
P/E (TTM)
—
EPS (TTM)
-2.43
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.56
PEG Ratio
—
Return on Equity
-38.96%
Return on Assets
-23.71%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
13.92
Debt/Equity
0.03
Total Debt
$7.75M
Free Cash Flow
$-40.31M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$-82.49M

Market Snapshot

About

Sionna Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for inflammatory and fibrotic diseases. The company utilizes its proprietary TRADE platform to discover and develop small molecule therapeutics targeting critical disease pathways.